EXHIBIT 4.14


                              CONSULTING AGREEMENT
                              --------------------


     THIS CONSULTING AGREEMENT (this "Agreement") is made and entered into by
and between CELSION CORPORATION, a Delaware Corporation, which has an address of
10220-I Old Columbia Road, Columbia, Maryland 21046-1705 ("Celsion"), and GLORIA
LI, Ph.D. who has an address of 1275 York Avenue, New York, NY 10021
("Consultant").

     WHEREAS, Consultant is a researcher specializing in the treatment of
cancer, with expertise in the use of gene therapy (as defined below), together
with various activities relative thereto; and,

     WHEREAS, Celsion develops and manufactures medical devices including a
device for the treatment of cancer utilizing microwave technology (the
"Device"); and,

     WHEREAS, Celsion desires to provide an incentive for Consultant to render
her advice and assistance to Celsion; and,

     WHEREAS, Consultant is willing to advise and assist Celsion on the basis
set forth herein and for the consideration herein named.

     NOW, THEREFORE, in consideration of the foregoing, of the mutual promises
of the parties hereto, and of other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto, intending
legally to be bound, hereby agree as follows:

2.   Services to be Performed.

     2.1  During the period of this Agreement, it is understood and agreed that
Consultant shall provide her consulting services and advice to Celsion in
connection with the following activities:

          2.1.1   Assist Celsion in recruiting sites for clinical trials using
                  the Device and gene therapy products under study;

          2.1.2   Work with Celsion to improve the efficacy of treatments with
                  the Device;

          2.1.3   Work with Celsion to improve the design of the Device;

          2.1.4   Simplify and standardize treatment protocols;

          2.1.5   Work with Celsion to assess new opportunities in gene therapy
                  for Celsion's Device;



          2.1.6   Assist Celsion in evaluating manufacturers for the drug
                  components;

          2.1.7   Host or visit physicians, allied health professionals,
                  selected sales representatives and Celsion employees at
                  selected institutions for the purposes of product
                  demonstration and medical education;

          2.1.8   Be available to speak at, or participate in, medical meetings,
                  symposia, seminars, workshops, etc. as a means to support the
                  educational efforts on Celsion's methodology. These meetings
                  may be administered by medical associations, universities,
                  medical teaching programs or commercial entities such as
                  Celsion;

          2.1.8   Participate in the preparation of those materials required to
                  support the educational efforts of Celsion regarding microwave
                  technology for the treatment of cancer;

          2.1.9   Be available to speak/meet with shareholders analysts and
                  potential investors of Celsion.

     2.2  It is the intention of the parties that the above listed services
shall not require full-time efforts on Consultant's part. The parties anticipate
that Consultant will provide the approximate equivalent of fifteen (15) hours of
service per month. It is understood and agreed that Consultant will maintain her
current employment commitments and professional responsibilities and the
services to be provided hereunder by Consultant shall be at such times and in
such amounts as will allow those commitments and responsibilities to be met.

     2.3  Consultant is solely an independent contractor hereunder, rather than
an employee of Celsion, or a co-venturer, partner, agent or representative of
Celsion.

3.   Compensation. Celsion shall compensate Consultant as follows:

     3.1  Consultant shall be compensated with 5,000 shares of Celsion Common
          stock for the month October 2001 through March 2002. Afterwards
          Consultant shall receive the equivalent of $2500 per month, said sum
          to be converted into shares of Celsion Common stock. The price of
          these shares shall be equal to the closing price of the stock at the
          end of each quarter (i.e. December 31, March 31, June 30, and
          September 30).

     3.5  Out of Pocket Expenses. Consultant shall be fully and entirely
          reimbursed by Celsion for any and all reasonable out-of-pocket costs
          and expenses incurred by Consultant in connection with any activity
          or service of Consultant hereunder. With respect to any such
          reimbursement, Consultant shall present Celsion with such invoices, in
          such detail and with such receipts as are necessary to substantiate
          such reasonable out-of-


                                       2



          pocket costs and expenses. Any individual expense in excess of $500
          shall be pre-approved by Celsion.

4.   Term: Termination of Agreement.

     4.1  The term of this Agreement shall commence October 1, 2001 and shall
end September 30, 2002 (the "Termination Date"). Upon the mutual agreement of
the parties. The agreement will automatically renew for a further twelve
(12)-month period subject to exercise of the provisions contained in clauses
4.2, 4.3 or 4.4 hereof.

     4.2  During the term hereof Celsion shall have the right at its option to
terminate this Agreement by giving ten (10) days prior written notice thereof to
Consultant in the event of any of the following:

          4.2.1   If Consultant has breached any provisions of this Agreement
                  and has failed to cure such breach within sixty (60) days of
                  written notice from Celsion describing such breach;

          4.2.2   If Consultant fails or refuses or is unable for any reason
                  (other than physical or mental capacity) substantially to
                  carry out or substantially to perform the duties required of
                  her hereunder for a substantially continuous period of sixty
                  (60) days, and does not resume her duties prior to the
                  termination date specified in Celsion a written notice of
                  termination;

          4.2.3   If Consultant is unable to carry out or perform the duties
                  required of her hereunder due to physical or mental incapacity
                  for a substantially continuous period of one hundred twenty
                  (120) days; or

     4.3  During the term hereof Consultant shall have the right at its option
to terminate this Agreement by giving ten (10) days prior written notice thereof
to Celsion in the event of any of the following:

          4.3.1   If Celsion has breached any provisions of this Agreement and
                  has failed to cure such breach within sixty (60) days of
                  written notice from Consultant describing such breach,
                  including, but not limited to, the failure of Celsion to make
                  any payments to Consultant that are called for under this
                  agreement;

          4.3.2   If Celsion shall file a voluntary petition in bankruptcy or
                  reorganization, or make any assignment for the benefit of
                  creditors, or seek any similar relief under any present or
                  future statute, law or regulation relating to relief of
                  debtors, or be adjudicated a bankrupt or have any involuntary
                  petition in bankruptcy filed against it which is not removed
                  within sixty (60) days of said filing.


                                       3



     4.4  Upon the termination of this Agreement, Celsion shall have no further
liability to Consultant other than to pay Consultant any fees due Consultant for
her services between the last day of the preceding month and the Termination
Date, which Celsion shall pay to Consultant within thirty (30) days after the
Termination Date.

     4.5  The parties agree that in the event that either Consultant or Celsion
determines that this Agreement does not comply with all applicable state and
federal laws and regulations, that the parties shall first attempt to
restructure this Agreement such that the Agreement is in compliance with all
applicable laws and regulations. In the event the parties fail to restructure
the Agreement, then either party shall have the right to immediately terminate
the Agreement, and in such case, all payments shall terminate.

5.   Competition with Celsion.

     During the term of this Agreement, Consultant will not engage in, consult
with, participate in as a designing or consulting Consultant or carry on,
directly or indirectly, any business in competition with a cancer treatment
device that is manufactured, marketed, distributed or sold by Celsion, either
for himself, as a member of a partnership, as a stockholder (except as a
stockholder of less than one percent (1%) of the issued and outstanding stock of
a publicly-held corporation whose gross assets exceed one hundred million
dollars) or as an investor, officer, director, consultant, agent or associate of
any person, partnership, corporation or other entity (other than Celsion or a
parent, subsidiary, affiliate or successor of Celsion) that is in such business.

6.   Disclosures of Information.

     6.1  Both parties acknowledge that in the course of their relationship,
they may receive certain information and data, including, but not limited to,
works of authorship (including, but not limited to, computer programs, software
and documentation); inventions, ideas, developments or innovations, trade
secrets, programs, methods of operation and other confidential information and
knowledge concerning the other party's business (hereinafter collectively
referred to as "Information") that each party desires to protect. As a material
inducement to Celsion to enter into this Agreement and to pay to Consultant the
compensation referred to in Section 3 hereof, and as a material inducement to
Consultant to provide the services required by this Agreement, each party
covenants and agrees that it will not, at any time during or following the term
of this Agreement, directly or indirectly, divulge or disclose, for any purpose
whatsoever, any of such Information which has been obtained by or disclosed to
it as a result of this Agreement which has been marked as either "Confidential"
or "Proprietary" or with some other designation that conveys the proprietary
and/or confidential nature of the materials. Consultant further agrees that she
will at no time use the Information in competing with Celsion. Upon termination
of this Agreement, each party shall surrender to the other all lists, books,
records, literature, products, papers, documents, writings, and other property
produced by her or it or coming into her or its possession by or through her or
its engagement or relating to the Information, and each party agrees that all
such materials will at all times remain the property of the other.


                                       4



     6.2  The parties hereto agree that if any restriction and/or remedy
contained in this Section 6 is held by any court to be unenforceable, or
unreasonable, the court shall reform and enforce a lesser restriction and/or
remedy in its place and the remaining restrictions and/or remedies contained
herein shall be severable from such unreasonable or unenforceable restrictions
and/or remedies, and the reformed restrictions and/or remedies together with the
remaining restrictions and/or remedies shall remain fully in effect and
enforceable.

     6.3  The provisions of this Section 6 shall survive the termination of this
Agreement.

     6.4  The Information referred to in Section 6.1 does not consist of any
information or data provided to either party in accordance with this Agreement:

          6.4.1   which is, or shall have been, in the other party's possession
                  prior to disclosure thereof;

          6.4.2   which is, or through no fault of the party to be charged,
                  becomes published or otherwise available to others or the
                  public under circumstances such that such others or the public
                  may utilize the same without any direct or indirect obligation
                  to the ;

          6.4.3   which is, or at any time may be, acquired by Consultant or
                  Celsion from any third party rightfully possessed of the same
                  and having no direct or indirect obligation to Consultant or
                  Celsion with respect to same;

          6.4.4   if keeping such Information confidential would be inconsistent
                  with Consultant's professional responsibilities; or

          6.4.5   if Consultant or Celsion is required by law to disclose the
                  Information, provided that either party shall timely notify
                  the other and allow the opportunity to challenge such request
                  prior to disclosure.

7.   Severability.

     Each of the foregoing covenants and agreements of Consultant and Celsion
shall be separate. If in any judicial proceeding a court shall refuse to enforce
all of said separate covenants and agreements that are sought to be enforced,
then such unenforceable covenants and agreements shall be deemed eliminated from
the provisions hereof for purposes of such proceeding to the extent necessary to
permit the remaining separate covenants and agreements to be enforced in such
proceeding.


                                       5



8.   Equitable Relief.

     Consultant and Celsion agree that the remedy at law for any breach by her
or it of this Agreement will be inadequate and that, should Consultant engage in
any activities prohibited by this Agreement or otherwise violate the provisions
hereof, Celsion or Consultant shall have the right, in addition to any other
rights or remedies available to Celsion or Consultant under this Agreement or
under applicable law or otherwise, to enjoin such activities without the
necessity of proof of actual damage and to obtain any other equitable relief
which a court may grant.

9.   Indemnification.

     9.1  Celsion covenants and agrees to indemnify and hold harmless
Consultant, and his agents, absolutely, unconditionally and forever, from and
against any and all claims, liabilities or damages arising out of or resulting
from the gross negligence or willful misconduct of Celsion.

     9.2  Consultant covenants and agrees to indemnify and hold harmless
Celsion, and his agents, absolutely, unconditionally and forever, from and
against any and all claims, liabilities or damages arising out of or resulting
from the gross negligence or willful misconduct of Consultant.

10.  Miscellaneous.

     10.1 No waiver of any provision of this Agreement shall be valid unless the
same is in writing and signed by the party against whom it is sought to be
enforced. No waiver of any provision of this Agreement at any time will be
deemed a waiver of any other provision of this Agreement at such time or will be
deemed a waiver of such provision at any other time. No modification of this
Agreement shall be binding unless in writing and signed by the party against
whom it is sought to be enforced.

     10.2 The provisions of this Agreement shall be deemed severable, and the
invalidity or unenforceability of any provision shall not affect the validity
and enforceability of the other provisions hereof.

     10.3 The captions and headings contained herein are solely for convenience
and do not constitute a part of this Agreement. Wherever appropriate herein,
the use of any gender herein shall be deemed to be or include the other genders,
and the use of the singular shall be deemed to be or include the plural (and
vice versa).

     10.4 All notices and other communications hereunder or in connection
herewith shall be deemed to have been duly given if delivered personally or if
sent by registered or certified mail in writing, return receipt requested, and
first-class postage prepaid. (i) if to Celsion: 10220-I Old Columbia Road,
Columbia, Maryland 21046-1705; and (ii) if to Consultant: 1275 York Avenue, New
York, NY 10021, unless notice of change of address is given to either party by
the other pursuant to the provisions of this Section.


                                       6



     10.5  This Agreement is executed in, and it is the intention of the parties
hereto that the construction, enforcement and interpretation of this Agreement,
and the rights and liabilities of the parties hereto, shall be governed by and
interpreted under the laws of the State of Maryland; provided, however, the
scope and definition of Consultant's professional responsibilities shall be
governed by the State in which Consultant is licensed to practice medicine.

     10.6  This Agreement shall be binding upon, and shall inure to the benefit
of, the parties hereto and their respective executors or administrators, heirs,
legatees and beneficiaries, successors and, as permitted pursuant to this
Agreement, assigns.

     10.7  All claims, disputes and other matters in question between the
parties to this Agreement, arising out of or relating to this Agreement or the
breach thereof, shall be decided by arbitration in accordance with the
Arbitration Rules of the American Arbitration Association then obtaining unless
the parties mutually agree otherwise. Notice of the demand for arbitration shall
be filed in writing with the other party to this Agreement and with the American
Arbitration Association. The demand shall be made within a reasonable time after
the claim, dispute or other matter in question has arisen. In no event shall the
demand for arbitration be made after the date when institution of legal or
equitable proceedings based on such claim, dispute or other matter in question
would be barred by the applicable statute of limitations. The award rendered by
the arbitrators shall be final, and judgment may be entered upon it in
accordance with applicable law in any court having jurisdiction thereof.

     10.8  If any action is asserted or brought to enforce this Agreement, the
party or parties prevailing in any such action are entitled to reimbursement,
and shall be reimbursed by the non-prevailing party or parties for all costs and
expenses (including, without limitation, attorneys and accounting fees and
expenses) reasonably incurred by the prevailing party or parties in asserting or
bringing such action; provided, however, if such action is asserted for monetary
damages and if the party or parties asserting same are only partially successful
in asserting or bringing any such action, they shall be entitled to
reimbursement hereunder for their costs and expenses only in the proportion that
the amount awarded to such prevailing party bears to the total amount for which
any such action is brought or asserted.

     10.9  The rights and remedies of Celsion under this Agreement may not,
without the consent of or notice to Consultant, be assigned to any parent,
subsidiary, affiliate or successor of Celsion. All covenants and agreements of
Consultant contained in this Agreement shall inure to the benefit of and be
enforceable by the successors and assigns of Celsion. All obligations of Celsion
shall be enforceable against the successors and assigns of Celsion in the event
that Celsion assigns this Agreement. The rights and obligations of Consultant
under the Agreement cannot be assigned without the prior written consent of
Consultant and Celsion.

     10.10 In the event that either party is in any way delayed, interrupted or
prevented from performing any of its obligations under this Agreement, and such
delay,


                                       7



interruption or prevention is due to fire, act of God, governmental act or
failure to act, strike, labor dispute, inability to procure materials, or any
other cause beyond the party's reasonable control, then the time for performance
of the affected obligation(s) by the party shall be excused for the period of
the delay and extended for a period equivalent to the period of such delay,
interruption or prevention.

     IN WITNESS WHEREOF, the parties hereto have hereunto affixed their
signatures to be effective as of the date and year first above written.


CONSULTANT                             CELSION CORPORATION


/s/ Gloria Li, Ph.D.                   By:    /s/ Augustine Y. Cheung
- --------------------                          -----------------------
Gloria Li, Ph.D.                       Name:  Augustine Y. Cheung
                                       Title: CEO


Date: November 23, 2001                Date:  November, 23, 2001


                                       8